| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 21 |
| NetGPI | no | yes: 0, no: 21 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005737 | cytoplasm | 2 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
| GO:0031974 | membrane-enclosed lumen | 2 | 1 |
| GO:0031981 | nuclear lumen | 5 | 1 |
| GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
| GO:0043233 | organelle lumen | 3 | 1 |
| GO:0070013 | intracellular organelle lumen | 4 | 1 |
| GO:0097014 | ciliary plasm | 5 | 1 |
| GO:0099568 | cytoplasmic region | 3 | 1 |
Related structures:
AlphaFold database: A4ID52
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 22 |
| GO:0016740 | transferase activity | 2 | 22 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 142 | 146 | PF00656 | 0.361 |
| CLV_NRD_NRD_1 | 168 | 170 | PF00675 | 0.564 |
| CLV_NRD_NRD_1 | 221 | 223 | PF00675 | 0.510 |
| CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.457 |
| CLV_NRD_NRD_1 | 78 | 80 | PF00675 | 0.465 |
| CLV_PCSK_KEX2_1 | 168 | 170 | PF00082 | 0.516 |
| CLV_PCSK_KEX2_1 | 221 | 223 | PF00082 | 0.459 |
| CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.456 |
| CLV_PCSK_KEX2_1 | 78 | 80 | PF00082 | 0.465 |
| CLV_PCSK_SKI1_1 | 221 | 225 | PF00082 | 0.477 |
| CLV_PCSK_SKI1_1 | 78 | 82 | PF00082 | 0.476 |
| CLV_PCSK_SKI1_1 | 95 | 99 | PF00082 | 0.558 |
| DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.551 |
| DEG_SCF_TRCP1_1 | 148 | 153 | PF00400 | 0.203 |
| DOC_CKS1_1 | 214 | 219 | PF01111 | 0.337 |
| DOC_PP2B_LxvP_1 | 268 | 271 | PF13499 | 0.422 |
| DOC_USP7_MATH_1 | 156 | 160 | PF00917 | 0.251 |
| DOC_WW_Pin1_4 | 1 | 6 | PF00397 | 0.686 |
| DOC_WW_Pin1_4 | 121 | 126 | PF00397 | 0.189 |
| DOC_WW_Pin1_4 | 150 | 155 | PF00397 | 0.265 |
| DOC_WW_Pin1_4 | 213 | 218 | PF00397 | 0.337 |
| LIG_14-3-3_CanoR_1 | 14 | 19 | PF00244 | 0.427 |
| LIG_14-3-3_CanoR_1 | 168 | 174 | PF00244 | 0.361 |
| LIG_14-3-3_CanoR_1 | 222 | 232 | PF00244 | 0.384 |
| LIG_BRCT_BRCA1_1 | 12 | 16 | PF00533 | 0.518 |
| LIG_BRCT_BRCA1_1 | 158 | 162 | PF00533 | 0.390 |
| LIG_FHA_1 | 1 | 7 | PF00498 | 0.553 |
| LIG_FHA_1 | 229 | 235 | PF00498 | 0.291 |
| LIG_FHA_1 | 237 | 243 | PF00498 | 0.318 |
| LIG_FHA_1 | 48 | 54 | PF00498 | 0.371 |
| LIG_FHA_2 | 140 | 146 | PF00498 | 0.265 |
| LIG_LIR_Gen_1 | 176 | 185 | PF02991 | 0.285 |
| LIG_LIR_Gen_1 | 31 | 41 | PF02991 | 0.306 |
| LIG_LIR_Nem_3 | 176 | 180 | PF02991 | 0.283 |
| LIG_LIR_Nem_3 | 31 | 36 | PF02991 | 0.315 |
| LIG_Pex14_1 | 177 | 181 | PF04695 | 0.268 |
| LIG_SH2_STAT3 | 266 | 269 | PF00017 | 0.368 |
| LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.286 |
| LIG_SH2_STAT5 | 213 | 216 | PF00017 | 0.242 |
| LIG_SH2_STAT5 | 266 | 269 | PF00017 | 0.376 |
| LIG_SH3_3 | 155 | 161 | PF00018 | 0.382 |
| LIG_SH3_3 | 239 | 245 | PF00018 | 0.504 |
| LIG_SH3_3 | 257 | 263 | PF00018 | 0.386 |
| LIG_TRFH_1 | 266 | 270 | PF08558 | 0.411 |
| MOD_CDK_SPxxK_3 | 1 | 8 | PF00069 | 0.495 |
| MOD_CK1_1 | 118 | 124 | PF00069 | 0.364 |
| MOD_CK1_1 | 141 | 147 | PF00069 | 0.314 |
| MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.465 |
| MOD_GlcNHglycan | 147 | 151 | PF01048 | 0.576 |
| MOD_GlcNHglycan | 182 | 185 | PF01048 | 0.508 |
| MOD_GlcNHglycan | 72 | 75 | PF01048 | 0.465 |
| MOD_GSK3_1 | 10 | 17 | PF00069 | 0.577 |
| MOD_GSK3_1 | 139 | 146 | PF00069 | 0.392 |
| MOD_GSK3_1 | 150 | 157 | PF00069 | 0.389 |
| MOD_GSK3_1 | 180 | 187 | PF00069 | 0.288 |
| MOD_N-GLC_1 | 118 | 123 | PF02516 | 0.465 |
| MOD_NEK2_1 | 223 | 228 | PF00069 | 0.298 |
| MOD_PK_1 | 169 | 175 | PF00069 | 0.265 |
| MOD_PKA_2 | 207 | 213 | PF00069 | 0.280 |
| MOD_Plk_1 | 138 | 144 | PF00069 | 0.294 |
| MOD_Plk_2-3 | 139 | 145 | PF00069 | 0.265 |
| MOD_ProDKin_1 | 1 | 7 | PF00069 | 0.688 |
| MOD_ProDKin_1 | 121 | 127 | PF00069 | 0.189 |
| MOD_ProDKin_1 | 150 | 156 | PF00069 | 0.265 |
| MOD_ProDKin_1 | 213 | 219 | PF00069 | 0.337 |
| TRG_DiLeu_BaLyEn_6 | 219 | 224 | PF01217 | 0.294 |
| TRG_ER_diArg_1 | 168 | 170 | PF00400 | 0.361 |
| TRG_ER_diArg_1 | 221 | 223 | PF00400 | 0.310 |
| TRG_ER_diArg_1 | 28 | 30 | PF00400 | 0.258 |
| TRG_ER_diArg_1 | 77 | 79 | PF00400 | 0.359 |
| TRG_Pf-PMV_PEXEL_1 | 78 | 82 | PF00026 | 0.465 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P896 | Leptomonas seymouri | 35% | 100% |
| A0A0N1PCD6 | Leptomonas seymouri | 60% | 99% |
| A0A0S4IK22 | Bodo saltans | 32% | 100% |
| A0A1X0NN04 | Trypanosomatidae | 32% | 100% |
| A0A1X0P3F1 | Trypanosomatidae | 43% | 83% |
| A0A3Q8I9N9 | Leishmania donovani | 33% | 100% |
| A0A3R7K9Z6 | Trypanosoma rangeli | 47% | 95% |
| A0A3R7MES7 | Trypanosoma rangeli | 34% | 100% |
| A0A3S7XB94 | Leishmania donovani | 100% | 100% |
| A4H781 | Leishmania braziliensis | 32% | 100% |
| A4HPL2 | Leishmania braziliensis | 86% | 100% |
| A4HVM1 | Leishmania infantum | 32% | 100% |
| D0A6N3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 80% |
| D0A8K2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 93% |
| E9APB7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
| E9ATC4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
| Q4Q173 | Leishmania major | 93% | 100% |
| Q4QG61 | Leishmania major | 32% | 100% |
| V5BK55 | Trypanosoma cruzi | 34% | 100% |
| V5BS52 | Trypanosoma cruzi | 48% | 94% |